Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Novo Nordisk A/S (NVO) had Cash Flow from Investing Activities of $-6.37B for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$33.72B |
|
$12.15B |
|
$5.19B |
|
$28.53B |
|
$18.83B |
|
$14.89B |
|
$304.92M |
|
$15.20B |
|
$15.20B |
|
$12.15B |
|
$12.15B |
|
$12.15B |
|
$12.15B |
|
$14.89B |
|
$16.26B |
|
4.48B |
|
4.49B |
|
$2.71 |
|
$2.70 |
|
| Balance Sheet Financials | |
$20.28B |
|
$13.21B |
|
$25.39B |
|
$45.66B |
|
$24.63B |
|
$2.98B |
|
$5.56B |
|
$30.19B |
|
$15.47B |
|
$6.70B |
|
$15.47B |
|
4.51B |
|
| Cash Flow Statement Financials | |
$15.81B |
|
|
Cash Flow from Investing Activities |
$-6.37B |
$-9.17B |
|
$1.84B |
|
$2.09B |
|
$252.50M |
|
$312.03M |
|
$-4.61B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
0.16 |
|
0.25 |
|
84.60% |
|
44.16% |
|
44.16% |
|
48.22% |
|
45.07% |
|
36.03% |
|
$12.07B |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
1.12 |
|
3.09 |
|
118.27 |
|
78.53% |
|
181.31% |
|
26.61% |
|
65.85% |
|
$3.43 |
|
$2.68 |
|
$3.52 |
|